✦ LIBER ✦

Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology

✍ Scribed by A Kornberg; M Hommann; A Tannapfel; T.h Grube; U Schotte; J Scheele

Book ID: 117232489
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 48 KB
Volume: 34
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(02)03226-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy of interferon alpha-

Combination therapy of interferon alpha-2b and ribavirin for recurrent hepatitis C after liver transplantation

✍ M Castedal; A Siewert-Delle; M Olausson; S Friman 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Combination of interferon-α and ribaviri

Combination of interferon-α and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation

✍ Z Ben-Ari; E Mor; E Shaharabani; N Bar-Nathan; Z Shapira; R Tur-Kaspa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Long-term Combination of Interferon Alfa

Long-term Combination of Interferon Alfa-2b and Ribavirin for Hepatitis C Recurrence in Liver Transplant Patients

✍ Arno Kornberg; Merten Hommann; Andrea Tannapfel; Thomas Wagner; Thomas Grube; Uw 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Long-term ribavirin therapy in hepatitis

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology

✍ Nassim Kamar; Karine Sandres-Saune; Janick Selves; David Ribes; Olivier Cointaul 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Effects of double-filtration plasmaphere

Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation

✍ Yasutsugu Takada; Takashi Ito; Yoshihide Ueda; Hironori Haga; Hiroto Egawa; Koic 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Response rates to interferon and ribavirin treatment for recipients with recurrent hepatitis C virus (HCV) infection are suboptimal, particularly for those with genotype 1b and high viral load. The present study evaluated the effects of combining double-filtration plasmapheresis (DFPP) with pharmaco

Conversion from intravenous to intramusc

Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation

✍ Steven-Huy Han; Paul Martin; Marc Edelstein; Rena Hu; Gregg Kunder; Curtis Holt; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB